Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Drugs of Today (Barcelona, Spain : 1998)|November 6, 2013
Current treatment and future prospects for peripheral T-cell lymphomaT A Eyre, G P CollinsBritish Journal of Haematology|November 14, 2024
Measurable residual disease-driven treatment in first-line chronic lymphocytic leukaemiaM S Davids, K H Lin, A I Mohamed, et al.Blood Reviews|December 14, 2023
Richter's transformation: Transforming the clinical landscapeA Barrett, N Appleby, H Dreau, et al.Plos One|November 8, 2019
Correction: Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern eraF A Sharpley, P Neffa, F Panitsas, et al.British Journal of Cancer|October 6, 2021
Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in EnglandL Hounsome, T A Eyre, R Ireland, et al.Bone Marrow Transplantation|June 6, 2017
High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United KingdomS Kassam, E Chernucha, A O'Neill, et al.Journal of Internal Medicine|February 28, 2019
Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by ageT A Eyre, N Martinez-Calle, C Hildyard, et al.Pageof 1